Quick Answer
MAIA Biotechnology, Inc. reported Shares Outstanding of 38.62 million shares for fiscal year 2025.
MAIA Biotechnology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 38.62M | +47.7% |
| 2024 | 26.16M | +54.0% |
| 2023 | 16.99M | +55.0% |
| 2022 | 10.96M | +44.4% |
| 2021 | 7.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 34.45M | +43.7% | +8.3% |
| June 30, 2025 | 31.82M | +34.0% | +7.5% |
| March 31, 2025 | 29.59M | +43.8% | +13.1% |
| December 31, 2024 | 26.16M | +54.0% | +9.1% |
| September 30, 2024 | 23.97M | +74.2% | +1.0% |
| June 30, 2024 | 23.74M | +73.9% | +15.3% |
| March 31, 2024 | 20.58M | +87.2% | +21.2% |
| December 31, 2023 | 16.99M | +55.0% | +23.4% |
- MAIA Biotechnology, Inc. showed an increase of +47.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, MAIA Biotechnology, Inc.’s shares outstanding has grown by 409.2% (from 7.58 million shares to 38.62 million shares).
- The most recent figure is from MAIA Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: